Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Diabetes trial results

Completed

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

NCT00700960

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Paris La Défense, France

View Trial Details

Completed

Efficacy and Safety of Levemir® Used as Basal Insulin

NCT01548248

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Novo Nordisk Investigational Site Bratislava, Slovakia

View Trial Details

Completed

Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes

NCT00106366

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Birmingham, Alabama, United States

Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States

Novo Nordisk Investigational Site Little Rock, Arkansas, United States

Novo Nordisk Investigational Site Searcy, Arkansas, United States

View all 78 locations

View Trial Details

Completed

Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®

NCT00658099

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Bucharest, Romania

View Trial Details

Completed

An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

NCT01542424

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Novo Nordisk Investigational Site Skopje, North Macedonia

View Trial Details

Completed

Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes

NCT00704574

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Lund, Sweden

View Trial Details

Completed

Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos

NCT01542489

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations: Novo Nordisk Investigational Site Bratislava, Slovakia

View Trial Details

Completed

Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan

NCT01497587

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
Locations: Novo Nordisk Investigational Site Taipei, Taiwan

View Trial Details

Completed

Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes

NCT00104182

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Birmingham, Alabama, United States

Novo Nordisk Investigational Site Mesa, Arizona, United States

Novo Nordisk Investigational Site Phoenix, Arizona, United States

Novo Nordisk Investigational Site Anaheim, California, United States

View all 96 locations

View Trial Details

Completed

Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes

NCT01497574

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Hanover, Germany

View Trial Details